eNavvi and Cost Plus Drugs Expand Relationship to Enhance Prescription Access

LOS ANGELES, Oct. 31, 2024 /PRNewswire/ -- eNavvi, Inc., a leader in the prescription marketplace, and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) are excited to announce a strategic collaboration that enables physicians to prescribe medications directly through eNavvi's digital...